{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:02Z","timestamp":1787020922837,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200712"],"award-info":[{"award-number":["82200712"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Dyskeratosis congenita is a rare genetic disease due to telomere biology disorder and characterized by heterogeneous clinical manifestations and severe complications. \u201cPorto-sinusoidal vascular disease\u201d has been recently proposed, according to new diagnostic criteria, to replace the term \u201cidiopathic non-cirrhotic portal hypertension.\u201d TERT plays an important role in telomeric DNA repair and replication. A\n                      <jats:italic>TERT<\/jats:italic>\n                      c.2286\u2009+\u20091G\/A mutation in a splicing consensus site was identified in a patient with pulmonary fibrosis. Recently, a pathogenic de novo\n                      <jats:italic>TERT<\/jats:italic>\n                      c.280A\u2009&gt;\u2009T variant was associated with diffuse lung disease in an infant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 16-year-old Han male patient experienced unexplained black stool for 7\u00a0days, accompanied by dizziness and fatigue. On examination, there were mesh pigmentations on the exposed areas of the skin on both hands and feet. Laboratory testing revealed moderate hemorrhagic anemia and mild elevation of alanine aminotransferase. A computed tomography scan showed portal hypertension, esophageal and gastric varices, and splenomegaly. The liver stiffness measurement by FibroScan was 6.0\u00a0kPa. Liver biopsy revealed typical features of porto-sinusoidal vascular disease. Whole exome sequencing identified a heterozygous\n                      <jats:italic>TERT<\/jats:italic>\n                      c.2286\u2009+\u20091G\u2009&gt;\u2009A de novo mutation and quantitative polymerase chain reaction revealed very short telomeres (less than the first percentile for his age). The patient was diagnosed as\n                      <jats:italic>TERT<\/jats:italic>\n                      de novo mutation-related dyskeratosis congenita and porto-sinusoidal vascular disease. He underwent esophageal and gastric variceal ligation treatment and received a carvedilol tablet (12.5\u00a0mg) every morning. After 6\u00a0months, he has moderate iron deficiency anemia and has started receiving polysaccharide iron complex therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>When discovering reticular rash and unknown portal hypertension, it is necessary to perform whole exome sequencing and chromosome length testing to clarify the possibility of dyskeratosis congenita\/telomere biology disorder with porto-sinusoidal vascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-025-05031-6","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T14:39:17Z","timestamp":1737643157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TERT de novo mutation-associated dyskeratosis congenita and porto-sinusoidal vascular disease: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Ge","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijie","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"5031_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/genes13030496","author":"M Callea","year":"2022","unstructured":"Callea M, Martinelli D, Cammarata-Scalisi F, et\u00a0al. Multisystemic manifestations in rare diseases: the experience of dyskeratosis congenita. Genes. 2022. https:\/\/doi.org\/10.3390\/genes13030496.","journal-title":"Genes"},{"issue":"6","key":"5031_CR2","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/hep.0000000000000461","volume":"78","author":"A Vittal","year":"2023","unstructured":"Vittal A, Niewisch MR, Bhala S, et\u00a0al. Progression of liver disease and portal hypertension in dyskeratosis congenita and related telomere biology disorders. Hepatology. 2023;78(6):1777\u201387. https:\/\/doi.org\/10.1097\/hep.0000000000000461.","journal-title":"Hepatology"},{"key":"5031_CR3","doi-asserted-by":"publisher","first-page":"949435","DOI":"10.3389\/fonc.2022.949435","volume":"12","author":"M Fiesco-Roa","year":"2022","unstructured":"Fiesco-Roa M, Garc\u00eda-de Teresa B, Leal-Anaya P, et\u00a0al. Fanconi anemia and dyskeratosis congenita\/telomere biology disorders: two inherited bone marrow failure syndromes with genomic instability. Front Oncol. 2022;12:949435. https:\/\/doi.org\/10.3389\/fonc.2022.949435.","journal-title":"Front Oncol"},{"issue":"4","key":"5031_CR4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jaad.2017.10.017","volume":"78","author":"SC Ward","year":"2018","unstructured":"Ward SC, Savage SA, Giri N, et\u00a0al. Beyond the triad: inheritance, mucocutaneous phenotype, and mortality in a cohort of patients with dyskeratosis congenita. J Am Acad Dermatol. 2018;78(4):804\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2017.10.017.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"5031_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/s2468-1253(19)30047-0","volume":"4","author":"A De Gottardi","year":"2019","unstructured":"De Gottardi A, Rautou PE, Schouten J, et\u00a0al. Porto-sinusoidal vascular disease: proposal and description of a novel entity. Lancet Gastroenterol Hepatol. 2019;4(5):399\u2013411. https:\/\/doi.org\/10.1016\/s2468-1253(19)30047-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"5031_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.dld.2023.07.023","volume":"56","author":"S Gioia","year":"2024","unstructured":"Gioia S, Baiocchini A, d\u2019Amati G, et\u00a0al. Porto-sinusoidal vascular disorder (PSVD): application of new diagnostic criteria in a multicenter cohort of patients. Dig Liver Dis. 2024;56(2):291\u20136. https:\/\/doi.org\/10.1016\/j.dld.2023.07.023.","journal-title":"Dig Liver Dis"},{"key":"5031_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/hmer.S282674","volume":"13","author":"S Gioia","year":"2021","unstructured":"Gioia S, Riggio O, Nardelli S, d\u2019Amati G, Ridola L. Identifying patients at high risk of developing non-cirrhotic portal hypertension. Hepat Med. 2021;13:105\u201311. https:\/\/doi.org\/10.2147\/hmer.S282674.","journal-title":"Hepat Med"},{"issue":"8","key":"5031_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/17474086.2022.2108784","volume":"15","author":"H Tummala","year":"2022","unstructured":"Tummala H, Walne A, Dokal I. The biology and management of dyskeratosis congenita and related disorders of telomeres. Expert Rev Hematol. 2022;15(8):685\u201396. https:\/\/doi.org\/10.1080\/17474086.2022.2108784.","journal-title":"Expert Rev Hematol"},{"issue":"12","key":"5031_CR9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","volume":"12","author":"MR Niewisch","year":"2019","unstructured":"Niewisch MR, Savage SA. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 2019;12(12):1037\u201352. https:\/\/doi.org\/10.1080\/17474086.2019.1662720.","journal-title":"Expert Rev Hematol"},{"issue":"2 & 3","key":"5031_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.61186\/ibj.3783","volume":"27","author":"M Khakzad","year":"2023","unstructured":"Khakzad M, Shahbazi Z, Naderi M, Karimipoor M. A de novo TINF2, R282C mutation in a case of dyskeratosis congenital founded by next-generation sequencing. Iran Biomed J. 2023;27(2 & 3):146\u201351. https:\/\/doi.org\/10.61186\/ibj.3783.","journal-title":"Iran Biomed J"},{"issue":"3","key":"5031_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/ijlh.13176","volume":"42","author":"K Terada","year":"2020","unstructured":"Terada K, Miyake K, Yamaguchi H, et\u00a0al. TERT and TERC mutations detected in cryptic dyskeratosis congenita suppress telomerase activity. Int J Lab Hematol. 2020;42(3):316\u201321. https:\/\/doi.org\/10.1111\/ijlh.13176.","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"5031_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3324\/haematol.12317","volume":"93","author":"L Basel-Vanagaite","year":"2008","unstructured":"Basel-Vanagaite L, Dokal I, Tamary H, et\u00a0al. Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations. Haematologica. 2008;93(6):943\u20134. https:\/\/doi.org\/10.3324\/haematol.12317.","journal-title":"Haematologica"},{"issue":"1","key":"5031_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13023-019-1046-0","volume":"14","author":"EG Arias-Salgado","year":"2019","unstructured":"Arias-Salgado EG, Galvez E, Planas-Cerezales L, et\u00a0al. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes. Orphanet J Rare Dis. 2019;14(1):82. https:\/\/doi.org\/10.1186\/s13023-019-1046-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"5031_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2478\/bjmg-2024-0008","volume":"27","author":"J Visekruna","year":"2024","unstructured":"Visekruna J, Basa M, Grba T, et\u00a0al. Ultra-early diffuse lung disease in an infant with pathogenic variant in telomerase reverse transcriptase (TERT) gene. Balkan J Med Genet. 2024;27(1):59\u201363. https:\/\/doi.org\/10.2478\/bjmg-2024-0008.","journal-title":"Balkan J Med Genet"},{"issue":"7","key":"5031_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00403-024-03050-9","volume":"316","author":"C Neri Morales","year":"2024","unstructured":"Neri Morales C, Cuestas D, \u00c1ngel F, et\u00a0al. Dyskeratosis congenita associated with a novel missense variant in TERT: approach for the dermatologists. Arch Dermatol Res. 2024;316(7):438. https:\/\/doi.org\/10.1007\/s00403-024-03050-9.","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"5031_CR16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/15476286.2015.1094596","volume":"13","author":"AA Bertuch","year":"2016","unstructured":"Bertuch AA. The molecular genetics of the telomere biology disorders. RNA Biol. 2016;13(8):696\u2013706. https:\/\/doi.org\/10.1080\/15476286.2015.1094596.","journal-title":"RNA Biol"},{"key":"5031_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.170","author":"I Dokal","year":"2015","unstructured":"Dokal I, Vulliamy T, Mason P, Bessler M. Clinical utility gene card for: dyskeratosis congenital\u2014Update 2015. Eur J Hum Genet. 2015. https:\/\/doi.org\/10.1038\/ejhg.2014.170.","journal-title":"Eur J Hum Genet"},{"key":"5031_CR18","unstructured":"Savage SA, Niewisch MR. Dyskeratosis Congenita and Related Telomere Biology Disorders. In: Adam MP, Feldman J, Mirzaa GM, et\u00a0al., editors. GeneReviews. Seattle: University of Washington, Seattle"},{"key":"5031_CR19","doi-asserted-by":"crossref","unstructured":"Vulliamy T, Dokal I. Dyskeratosis congenita. Semin Hematol. 2006;43(3):157\u2013166.","DOI":"10.1053\/j.seminhematol.2006.04.001"},{"issue":"3","key":"5031_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.seminhematol.2006.04.001","volume":"43","author":"T Vulliamy","year":"2006","unstructured":"Vulliamy T, Dokal I. Dyskeratosis congenita. Semin Hematol. 2006;43(3):157\u201366. https:\/\/doi.org\/10.1053\/j.seminhematol.2006.04.001.","journal-title":"Semin Hematol"},{"issue":"5","key":"5031_CR21","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","volume":"110","author":"BP Alter","year":"2007","unstructured":"Alter BP, Baerlocher GM, Savage SA, et\u00a0al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood. 2007;110(5):1439\u201347. https:\/\/doi.org\/10.1182\/blood-2007-02-075598.","journal-title":"Blood"},{"issue":"4","key":"5031_CR22","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","volume":"77","author":"A De Gottardi","year":"2022","unstructured":"De Gottardi A, Sempoux C, Berzigotti A. Porto-sinusoidal vascular disorder. J Hepatol. 2022;77(4):1124\u201335. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.033.","journal-title":"J Hepatol"},{"issue":"11","key":"5031_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007926","volume":"4","author":"RT Calado","year":"2009","unstructured":"Calado RT, Regal JA, Kleiner DE, et\u00a0al. A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS ONE. 2009;4(11): e7926. https:\/\/doi.org\/10.1371\/journal.pone.0007926.","journal-title":"PLoS ONE"},{"issue":"6","key":"5031_CR24","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1002\/hep.30578","volume":"69","author":"D Kapuria","year":"2019","unstructured":"Kapuria D, Ben-Yakov G, Ortolano R, et\u00a0al. The spectrum of hepatic involvement in patients with telomere disease. Hepatology. 2019;69(6):2579\u201385. https:\/\/doi.org\/10.1002\/hep.30578.","journal-title":"Hepatology"},{"issue":"1","key":"5031_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/hep.31111","volume":"72","author":"JM Kolb","year":"2020","unstructured":"Kolb JM, Conzen K, Wachs M, et\u00a0al. Liver transplantation for decompensated cirrhosis secondary to telomerase reverse transcriptase mutation. Hepatology. 2020;72(1):356\u20138. https:\/\/doi.org\/10.1002\/hep.31111.","journal-title":"Hepatology"},{"issue":"2","key":"5031_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2012.09.011","volume":"58","author":"L Valenti","year":"2013","unstructured":"Valenti L, Dongiovanni P, Maggioni M, et\u00a0al. Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis. J Hepatol. 2013;58(2):399\u2013401. https:\/\/doi.org\/10.1016\/j.jhep.2012.09.011.","journal-title":"J Hepatol"},{"issue":"6","key":"5031_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12829","volume":"17","author":"R Maeso-D\u00edaz","year":"2018","unstructured":"Maeso-D\u00edaz R, Ortega-Ribera M, Fern\u00e1ndez-Iglesias A, et\u00a0al. Effects of aging on liver microcirculatory function and sinusoidal phenotype. Aging Cell. 2018;17(6): e12829. https:\/\/doi.org\/10.1111\/acel.12829.","journal-title":"Aging Cell"},{"issue":"4","key":"5031_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jhep.2021.05.014","volume":"75","author":"V Hern\u00e1ndez-Gea","year":"2021","unstructured":"Hern\u00e1ndez-Gea V, Campreci\u00f3s G, Betancourt F, et\u00a0al. Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease. J Hepatol. 2021;75(4):924\u201334. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.014.","journal-title":"J Hepatol"},{"issue":"9","key":"5031_CR29","doi-asserted-by":"publisher","first-page":"101150","DOI":"10.1016\/j.jhepr.2024.101150","volume":"6","author":"N Pugliese","year":"2024","unstructured":"Pugliese N, Ponziani FR, Cerini F, et\u00a0al. Link between persistent, unexplained gamma-glutamyltransferase elevation and porto-sinusoidal vascular disorder. JHEP Rep. 2024;6(9):101150. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101150.","journal-title":"JHEP Rep"},{"issue":"10","key":"5031_CR30","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s11136-020-02532-3","volume":"29","author":"KW Lee","year":"2020","unstructured":"Lee KW, Ching SM, Hoo FK, et\u00a0al. Factors associated with poor-to-moderate quality of life among pregnant women with gestational diabetes mellitus: a cross-sectional study in Malaysia. Qual Life Res. 2020;29(10):2725\u201336. https:\/\/doi.org\/10.1007\/s11136-020-02532-3.","journal-title":"Qual Life Res"},{"issue":"1","key":"5031_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1186\/s12877-022-03424-6","volume":"22","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Rokhani FZ, Sazlina SG, Devaraj NK, Su J, Chew BH. Defining the concepts of a smart nursing home and its potential technology utilities that integrate medical services and are acceptable to stakeholders: a scoping review. BMC Geriatr. 2022;22(1):787. https:\/\/doi.org\/10.1186\/s12877-022-03424-6.","journal-title":"BMC Geriatr"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05031-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T14:39:19Z","timestamp":1737643159000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05031-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5031"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05031-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient provided written, informed consent for the publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests concerning this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}